RIM
HPTX

RS Investment Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

RS Investment Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-73,078
Closed -$1.61M – 351
2013
Q2 		$1.61M Buy
+73,078
New +$1.6M 0.01% 291

Other funds holding HPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RS Investment Management's HPTX Position: Q3 2013 in Review

RS Investment Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q3 2013, closing a stake of 73,078 shares — an estimated $1.61M sold.

RS Investment Management first reported a position in HPTX in Q2 2013 and held it in 1 quarter. The position peaked at $1.61M in Q2 2013. 61 funds tracked by Wall St. Rank hold HPTX as of Q3 2013.

  • RS Investment Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • RS Investment Management sold 73,078 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $1.61M.
  • RS Investment Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • RS Investment Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.61M in Q2 2013.
  • 61 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on RS Investment Management's 13F filing for Q3 2013, filed 15 Nov 2013.